Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
[3as-[2(s*),3a,4b,6b,7a]]-Hexahydro-3a,5,5-trimethyl-alpha-(1-methylethyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine Trifluoroacetate is an impurity of Bortezomib (B675700), Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.